Conference & Event Schedule

Conference & Event Schedule

Come and visit us at one of our upcoming events where our team will be available to tell you more about our Phenoptics Research Solutions for Cancer Immunology & Immunotherapy and answer your questions.

PerkinElmer Hosted Events

Online Webinar: The Beginning of the End: Immunoprofiling Coming of Age
Speaker: Bernard A. Fox, PhD
Chief of the Laboratory of Molecular and Tumor Immunology Providence Portland Medical Center

This webcast will provide a brief overview of multiplex immunofluorescence methods and then present results from a recent study demonstrating the prognostic power of assessing the composition and relationships of cells in the tumor microenvironment in-situ in FFPE tissue sections. These results provide insights into how this information could be used to stratify patients for enrollment on clinical trials, evaluate drug mechanisms of action and potentially identify patients in need of aggressive therapy. Ultimately, this capability should accelerate the development of immuno-oncology agent combinations and improve outcomes for patients with cancer.

During the webcast you will:

  • Gain a clearer understanding of multiplex immunofluorescence and how to characterize cell-level immuno-biology in intact FFPE tissue sections
  • See experimental evidence of the real-world application of multiplexing and how it can be applied to study the tumor microenvironment

 

Online Webinar: Using Multiplexed IHC to Effectively Navigate the Hidden Clues of the Immunological Microenvironment, in situ, of Cancer
Speaker: Edward Stack, PhD
Field Applications Scientist, PerkinElmer

Therapies like ipilimumab and nivolumab have shown the potential for approaches that direct the patient’s own immune system against tumors. Further advances will require a detailed understanding of the tumor microenvironment and characterization of the location and status of immune cells and their interaction with tumor cells. This will require methods that provide phenotyping of immune and cancer cells combined with the cytoarchitectonics of the tumor. To achieve this, a practical method for simultaneous immunohistochemistry of up to 8 biomarkers in a single tissue section using standard unlabeled primary antibodies will be described. In addition, approaches for multiplexed imaging, single cell quantitative analysis, automated phenotyping and bioinformatics that enable new insights into cancer biology and immunology will be presented. These will then be leveraged in analyses of multiple cancer types, where it is established that the host-tumor interaction is complex and difficult to characterize with standard immunohistochemistry or flow cytometry. But by leveraging multiplexed IHC in situ, we will demonstrate the unique spatial relationships of immune phenotypes in and around both epithelial and non-epithelial tumor types, and show how this data has the potential to form the basis of assays that can guide therapy and monitor response. Further data regarding functional assessment of regulatory immunologic co-factor expression will be discussed.

 

Online Webinar: Multiplexed Immunohistochemistry: Illuminating the Tumor Microenvironment to Study Cancer-immune Mechanisms
Speaker: Janis Taube, M.D., M.Sc
Johns Hopkins Hospital

As immuno-oncology takes center stage in the battle against cancer, the need for biomarkers has become even more acute, with response rates continuing in the 20%–30% range and the menu of options, including combination therapies, growing at an accelerating pace. The specific immunoarchitecture characteristics of the microenvironment in which a particular tumor grows may be both prognostic and predictive of response to these new immunotherapies. Multiplex immunofluorescence is the most effective, efficient way to identify specific immune cell types, their location, and their state of activation, as well as the presence of immunoactive molecular expression, all at the same time. This method is highly beneficial for exploring immune evasion mechanisms and finding potential biomarkers that allow researchers to assess the mechanism of action and predict and track response. This live, online seminar will take the viewer through validation of this multiplexing technique, including a comparison with singleplex immunofluorescence and standard (chromogenic) immunohistochemistry, as well as an assessment of intersite reproducibility and the influence of staining order on quantitation.

During the webinar, the viewers will:

  • Gain a clearer understanding of multiplex immunofluorescence and how it compares with singleplex and current immunohistochemical techniques
  • See experimental evidence of the real-world application of multiplexing and how it can be applied to study the tumor microenvironment.

 

Industry Events

JAN 4 - 7, 2017

2017 Precision Medicine Series: Opportunities and Challenges of Exploiting Synthetic Lethality in Cancer
San Diego, CA

 

FEB 2 - 4, 2017

European Molecular Biology Laboratory (EMBL)- Cancer Core Europe Conference on Cancer Immunotherapy
Heildelberg, Germany

 

FEB 2 - 5, 2017

3rd Annual Moffitt Pathology Symposium: Transforming Discovery Into Practice
Sarasota, FL

 

FEB 6 - 7, 2017

Novel Immunotherapeutics Summit (GTCBio)
San Diego, CA

 

FEB 17 - 19, 2017

TRCCC: Translational Research Cancer Centers Consortium
Seven Springs, PA

 

FEB 19 - 24, 2017

Molecular Medicine Triconf
San Francisco, CA

 

FEB 23 - 25, 2017

ASCO-SITC Clinical Immuno-Oncology Symposium 
Orlando, FL

 

MAR 4 - 10, 2017

2017 USCAP Annual Meeting (United States & Canadian Academy of Pathology)
San Antonio, TX

 

MAR 14 - 15, 2017

Next Gen Immuno-Oncology Congress
London, UK

 

MAR 14 - 16, 2017

ICI: Immune Checkpoint Inhibitors
Boston, MA

 

MAR 19 - 23, 2017

Cancer Immunology and Immunotherapy: Taking a Place in Mainstream Oncology (C7)
British Columbia, Canada

 

APR 1 - 5, 2017

2017 AACR Annual Meeting (American Association for Cancer Research)
Washington, D.C.

 

APR 20 - 22, 2017

Cancer Metastasis through the Lympohovascular System Biology and Treatment
San Francisco, CA

 

APR 21, 2017

Novel Frontiers in Detecting Cancer Metastasis
San Francisco, CA

 

APR 23 - 25, 2017

AACR-AHNS Head and Neck Cancer Conference: Optimizing Survival and Quality of Life through Basic, Clinical, and Translational Research
San Diego, CA

 

MAY 12 - 16, 2017

AAI: Immunology 2017 (The American Association of Immunologists)
Washington, D.C.

 

JUN 2 - 6, 2017

2017 ASCO Annual Meeting (American Society of Clinical Oncology)
Chicago, IL

 

JUN 25 - 28, 2017

10th Annual Canadian Cancer Immunotherapy Consortium
Ottawa, Canada

 

SEPT 6 - 9, 2017

2017 International Cancer Immunotherapy Conference
Mainz, Germany

 

SEPT 15 - 20, 2017

43rd Annual NSH Symposium/Convention
Orlando, FL

 

OCT 1 - 3, 2017

Pathology Visions 201
San Diego, CA

 

OCT 26 - 30, 2017

AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics
Philadelphia, PA

 

NOV 8 - 12, 2017

2017 SITC Annual Meeting (Society for Immunotherapy of Cancer)
National Harbor, MD


Multispectral Imaging Roadshows

PerkinElmer will be partnering with industry experts to host a series of local Lunch & Learn workshops in the United States. Join us to learn about how our technologies are transforming cancer research to provide better visualization and identification of cancer immunology biomarkers. We'll showcase our complete Phenoptics Research Solutions for Immuno-Oncology, from multiplex immunohistochemistry staining solutions, multispectral imaging systems, and advanced image-analysis software, and invite speakers from Indica Labs, Columbia University, and more! Sign up for one of our four roadshows. Limited spots available. Dates and locations to be released soon.

Personal Demo

Personal Demo

Contact us to arrange a personal demo with one of our imaging specialists.

For Research Use Only. Not for Use in Diagnostic Procedures.

** Resource Footer_BackToTop_Text does not exist in bundle /cancer-immunology/_system/labels.xml **